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Abstract
Background: Primary ciliary dyskinesia (PCD) is a genetic disorder characterized by impaired ciliary function, leading to
chronic sinopulmonary disease. The genetic causes of PCD are still evolving, while the diagnosis is often dependent on
finding a ciliary ultrastructural abnormality and immotile cilia. Here we report a novel gene associated with PCD but without
ciliary ultrastructural abnormalities evident by transmission electron microscopy, but with dyskinetic cilia beating.
Methods: Genetic linkage analysis was performed in a family with a PCD subject. Gene expression was studied in
Chlamydomonas reinhardtii and human airway epithelial cells, using RNA assays and immunostaining. The phenotypic
effects of candidate gene mutations were determined in primary culture human tracheobronchial epithelial cells transduced
with gene targeted shRNA sequences. Video-microscopy was used to evaluate cilia motion.
Results: A single novel mutation in CCDC65, which created a termination codon at position 293, was identified in a subject
with typical clinical features of PCD. CCDC65, an orthologue of the Chlamydomonas nexin-dynein regulatory complex
protein DRC2, was localized to the cilia of normal nasal epithelial cells but was absent in those from the proband. CCDC65
expression was up-regulated during ciliogenesis in cultured airway epithelial cells, as was DRC2 in C. reinhardtii following
deflagellation. Nasal epithelial cells from the affected individual and CCDC65-specific shRNA transduced normal airway
epithelial cells had stiff and dyskinetic cilia beating patterns compared to control cells. Moreover, Gas8, a nexin-dynein
regulatory complex component previously identified to associate with CCDC65, was absent in airway cells from the PCD
subject and CCDC65-silenced cells.
Conclusion: Mutation in CCDC65, a nexin-dynein regulatory complex member, resulted in a frameshift mutation and PCD.
The affected individual had altered cilia beating patterns, and no detectable ultrastructural defects of the ciliary axoneme,
emphasizing the role of the nexin-dynein regulatory complex and the limitations of certain methods for PCD diagnosis.
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Introduction
Primary ciliary dyskinesia (PCD) (OMIM# 244400) is a genetic
disorder characterized by impaired ciliary function, leading to
diverse clinical manifestations that include chronic sinopulmonary
disease, persistent middle ear effusions, laterality defects, and
infertility. Current diagnostic studies include transmission electron
microscopy (EM), cilia motion analysis, nasal nitric oxide (NO)
measurements, and more recently, genetic testing for disease-
causing mutant alleles. Most of these techniques are only available
at specialized centers [1,2]. Until recently, transmission EM has
been considered the cornerstone for PCD diagnosis based on the
initial descriptions of structural defects in ciliary axonemes from
affected subjects [3]. However, there is a current consensus that
the reliance on EM alone is inadequate to diagnose PCD [4].
The complex genetics of PCD is rapidly unfolding so that the
identification of PCD-causing mutations could lead to the
development of comprehensive genetic testing to overcome
current diagnostic limitations. In most cases, the disease is
expressed in an autosomal recessive pattern, and theoretically,
mutations in any of nearly 2000 proteins that assemble or
constitute a motile cilium could potentially cause disease [5]. To
date, 19 genes have been associated with PCD [6–28]. These
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genes can be classified into three groups: genes encoding proteins
that are components of the outer or inner dynein arms including
DNAH5, DNAI1, DNAL1, DNAI2, TXNDC3 and DNAH11; genes
encoding proteins implicated in axonemal organization of the
central pair microtubules, radial spokes and nexin-dynein regula-
tory complex (N-DRC) including CCDC39, CCDC40, CCDC164,
CCDC103, CCDC114, RSPH9, RSPH4A, and HYDIN; and genes
encoding proteins that are cytoplasmic and do not localize to the
ciliary axoneme, including HEATR2, DNAAF1, DNAAF2, DNAAF3
and LRRC6 [11,12,18,21,23–25,27]. The cytoplasmic proteins are
presumed to have roles in cilia assembly or protein transport, and
mutations lead to ultrastructural abnormalities. Of note, subjects
with DNAH11 (MIM 603339) mutations present with a clinical
phenotype consistent with PCD, but with no ultrastructural defects
detectable using standard transmission EM [15]. Mutations in
other genes such as CCDC39 (MIM 613798) and CCDC40 (MIM
613799) produce inconsistent ultrastructural abnormalities char-
acterized by disordered microtubules in only some respiratory cells
[14,19,20], which underscores the limitations of EM as a
diagnostic test for PCD [15].
Another diagnostic approach utilized for PCD has been the
detection of immotile or paralyzed cilia. However, it is increasingly
recognized that this is not a consistent finding for all cases of PCD
since a slow or altered pattern of ciliary motility may instead be
present [13,28]. To detect these changes, specialized instrumen-
tation and specific expertise is required. Furthermore, secondary
effects on cilia beat related to the presence of infection,
inflammation, or smoke exposure may obscure the findings [29].
Here, we report an individual with PCD with normal ciliary
ultrastructure as determined by electron microscopy, and altered
ciliary beating. Linkage analysis on the proband and his parents
revealed a single homozygous frameshift mutation in CCDC65,
also known as DRC2, which is a component of the nexin-dynein
regulatory complex (N-DRC). The latter is proposed to regulate
the activity of the dynein motors [30,31]. Mutations in DRC1,
another N-DRC protein, were previously associated with PCD
secondary to altered cilia beat pattern [28].
Materials and Methods
Subjects and Genetic Analysis
A subject with clinical features consistent with PCD, from a
non-consanguineous family of Ashkenazi-Jewish descent was
studied (Figure 1A and 1B). Genetic linkage analysis was
performed on the affected individual, siblings, and parents
(Figure 1A). Because of the common ethnic origin of the parents
in this family, we assumed a founder mutation transmitted in an
autosomal recessive manner. A search for homozygous regions was
performed on the DNA sample from the proband using the
GeneChip Human Mapping 250K Nsp Affymetrix Array as
previously described [32].
Ethics Statement
All individuals or their parents provided written informed
consent for diagnostic evaluation and genetic characterization.
The Hadassah-Hebrew University Human Subjects Committee
Figure 1. Family pedigree and genetic analyses. (A) Pedigree of subject with PCD from an Ashkenazi-Jewish family. The closed symbol
represents the affected individual and symbols with central closed circles represent heterozygous individuals. (B) Computerized x-ray tomography of
the chest of the affected individual showing bronchiectasis. (C) Transmission electron microscopy of cilia from an affected individual failed to show
structural defects. (D) Chromatogram showing the nucleotide sequence of the CCDC65 exon 6 adjacent to the mutation site, at position
c.876_877delAT (ch12:47598804-5), which is predicted to result in frameshift leading to a premature termination codon.
doi:10.1371/journal.pone.0072299.g001
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and Washington University Human Research Protection Office
approved the study protocol. Also used in this study were
anonymized human airway epithelial cells from surgical excess
of large airways of lung donated for transplantation at Washington
University in St. Louis that were trimmed during the transplant
procedure. Research using cells originating from deidentified
cadaver specimens (surgical excess of large airways of lung) are
exempt from regulation and is not governed by NIH regulation 45
CFR Part 46.
Clinical Assessment
Disease severity assessment was quantified by chest computer-
ized x-ray tomography (CT) scans using the Brody score for
grading bronchiectasis, adapted from its original use in cystic
fibrosis bronchiectasis to non-CF bronchiectasis, including PCD
[33]. Nasal nitric oxide was measured using a CLD 88sp NO
analyzer (ECO MEDICS AG, Switzerland) according to the
manufacturer protocols and as recommended by the joint
American Thoracic Society and European Respiratory Society
consensus statement [34].
Airway Epithelial Cells
Nasal epithelial cells from subjects were obtained from the
inferior turbinate by cytology brush [35]. Human tracheal airway
epithelial cells (hTEC) were isolated from surgical excess of large
airways (tracheobronchial segments) of normal lungs donated for
transplantation. Cells were expanded in culture then seeded on
supported filters (Transwell, Corning Inc., Corning, NY) and re-
differentiated using air-liquid interface conditions [36]. Cell
preparations were maintained in culture for four to ten weeks.
Video-microscopy Ciliary Motion Analysis
Nasal epithelial cells were collected from subjects with PCD by
nasal brushing and examined using previously published protocols
[4]. Samples were suspended in cell culture media in a 24-well
plate, and then imaged in laboratories at the clinical site using an
inverted microscope equipped with a phase contrast objective
(Eclipse TS-100; Nikon Corp. Tokyo, Japan) at 4006magnifica-
tion. Ten video sequences of each sample were recorded at room
temperature within 10 minutes of sample collection. Images were
captured at 120 frames per seconds, each for 3 seconds in length,
using a high-speed video camera (scA640, Basler AG, Ahrensburg,
Germany). Images were processed with the Sisson-Ammons Video
Analysis system (Ammons Engineering, Mt. Morris, MI, USA)
using established methodologies [37]. Ciliary beating patterns of
the PCD subject were qualitatively evaluated using slow motion
playback (at 1/8th speed) of video sequences.
Video-microscopy of cultured airway epithelial cells was
performed at Washington University. Cultured airway epithelial
cells grown at an air-liquid interface were first scraped from
Transwell filters. Video-microscopy of ciliated epithelial cells was
performed using an inverted microscope with a phase contrast
objective (Eclipse Ti-U; Nikon, Melville, NY) enclosed in a
customized environmental chamber maintained at 37uC to
minimize secondary effects on cilia activity from temperature
fluctuations. The motion of cilia on cells clusters was viewed from
the side and captured by a high-speed video-microscopy. Cilia
velocity fields within groups of cilia were evaluated by estimating
optical flow in a region of interest containing the cilia [38,39]. The
Fast Fourier Transform (FFT) was then used to find a velocity
spectrum, which describes velocity amplitude as a function of
frequency. CBF was estimated as the frequency corresponding to
the highest peak of the velocity spectrum. We believe that
estimates of CBF from velocity fields are more reliable than
estimates from image intensity fields, since velocities of forward
and recovery strokes differed more clearly than intensities.
Gene Silencing of Airway Epithelial Cells
CCDC65 expression was silenced using an RNAi approach in
primary airway epithelial cells [11,40]. Human airway epithelial
cells were transduced with non-targeted or CCDC65-specific
shRNA sequences using a recombinant lentivirus vector that
contained a cassette to confer puromycin resistance. The shRNA-
targeted sequences used were those generated by The RNA
Consortium shRNA library in the pLKO.1 plasmid [40] provided
by the shRNA core facility of the Children’s Discovery Institute of
St. Louis Children’s Hospital and Washington University School
of Medicine. Vesicular stomatitis virus envelope glycoprotein
(VSV-G)-pseudotyped virus was generated by three-plasmid
cotransfection of HEK 293T cells using Fugene 6 (Roche, WI).
The virus generated in airway cell medium was filtered and used
to transduce hTEC. Tranduced cells were then selected by adding
puromycin (2.5 mg/ml) to the culture medium for 5 days [41].
Once confluent, airway epithelial cells were grown at an air-liquid
Figure 2. Expression of CCDC65 and its relationship with Foxj1 and ciliogenesis. (A) CCDC65 expression, relative to Foxj1measured using RT-
PCR, increased following the onset of ciliogenesis on air-liquid interface culture days 10 to 14 (p,0.0001; ANOVA). (B) CCDC65 expression determined
by RNA sequencing at the indicated times after C. reinhardtii deflagellation, which resulted in marked increase in DRC2 expression, the algal CCDC65
orthologue.
doi:10.1371/journal.pone.0072299.g002
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interface. shRNA sequences used were: CCAAGGAGTTTGA-
GACAGAAA (shRNA#1); CCAAACATTTGAACGAGTGGT
(shRNA#2); GCAAGATATCTTCATGGCCAT (shRNA#3);
and GCTGCTTCTGTTTCAGCAGAA (shRNA#4). A non-
targeted sequence subcloned into a plasmid containing the yellow
fluorescent protein (YFP) reporter and the puromycin resistance
genes (gift from Y. Feng and G.D. Longmore, Washington
University, St. Louis, MO) was used as a control sequence [42].
Reverse Transcriptase-polymerase Chain Reaction Assay
RNA was isolated from cells using the Illustra RNAspin kit (GE
Healthcare, Buckinghamshire, UK), reverse transcribed using a
cDNA Reverse Transcription Kit, then amplified and quantified
Figure 3. CCDC65 localization in ciliated airway epithelial cells. (A) Schematic of a ciliary axoneme cross section, with the N-DRC enlarged
(adapted from [30]). (B) Photomicrographs of CCDC65 immunofluorescent staining in nasal epithelial cells revealing cytoplasmic and axonemal
localization of the protein in normal cells compared to decreased expression in epithelial cells collected from the PCD subject (CCDC65, red;
acetylated a-tubulin, green; DAP, blue), Scale bar = 10 mm.
doi:10.1371/journal.pone.0072299.g003
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using the TaqMan Fast Universal PCR Master Mix (both from
Applied Biosystems, Carlsbad, CA) with SYBR green in a
Lightcycler 480 (Roche, Indianapolis, IN) [43]. Target gene
expression was normalized to Ornithine decarboxylase antizyme
(OAZ1) expression. CCDC65 and Foxj1 expression were assessed
using the following oligonucleotide primer sets: human CCDC65,
Figure 4. The effect of CCDC65 shRNA on cilia beat frequency of airway epithelial cells. (A) Mean (6 standard deviation) of cilia beat
frequency in nasal cells from non-PCD (NL) and PCD subject (PCD). (B) Mean cilia beat frequency in cells transduced with different targeted CCDC65
shRNA sequences (shown are the mean 6 standard deviation of n = 50 fields, p,0.0001; ANOVA).
doi:10.1371/journal.pone.0072299.g004
Figure 5. CCDC65 is involved in nexin-dynein regulatory complex (DRC) assembly. Photomicrographs of normal airway epithelial cells
following immunofluorescent staining for GAS8, a component of the N-DRC, which revealed ciliary localization of the protein but markedly reduced
levels in nasal epithelial cells from the PCD subject (GAS8, red; acetylated a-tubulin, green; DAPI, blue). Scale bar = 10 mm.
doi:10.1371/journal.pone.0072299.g005
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Epithelial Cell Immunofluorescent Staining and
Immunoblot Analyses
Human tracheobronchial epithelial cells from non-PCD
subjects differentiated at an air-liquid interface [36] or nasal
airway epithelial cells obtained from the inferior nasal turbinate
were fixed and immunostained as previously reported [36,44].
Primary antibodies and dilutions used included rabbit anti-
CCDC65 (1:100, Novus Biologicals, Littleton, CO), acetylated
a-tubulin (1:5000, clone 6-11-B1, Sigma Aldrich), GAS8 (1:100,
SAB1101111, Sigma Aldrich), and were detected with secondary
antibodies conjugated to Alexa Fluor dyes (A-21202, A-21206, A-
31570 and A-31572; Life Technologies, Grand Island, NY).
Nuclei were stained using 49, 6-diamidino-2-phenylindole (DAPI)
1.5 mg/mL (Vector laboratories, Burlingame, CA). Cells were
imaged using a Leica DM5000 epifluorescent microscope with
band-pass filter cubes optimized for the secondary dyes (Wetzlar,
Germany) and equipped with a Retiga 200R CCD camera (Q-
Imaging) interfaced with Q-Capture Pro software (Q-Imaging).
Images were adjusted globally using Photoshop (Adobe Systems,
San Jose, CA).
For immunoblot analyses, lysed cells were resolved by SDS-
PAGE (7.5%) then transferred to PVDF membranes. The blots
were incubated in blocking buffer of 1X TBS, 0.1% Tween-20
with 5% w/v nonfat dry milk, followed by incubation in blocking
buffer with the CCDC65 antibody (1:100 dilution). Signal was
detected using enhanced chemiluminescence.
Chlamydomonas Flagellar Deflagellation
Cells were grown on low-sulfur medium for 3 days in light and 2
days in the dark, and then differentiated into gametes over 4 hours
with the use of medium that lacks nitrogen; deflagellation was
induced by a pH shock [45]. Expression of CCDC65 was assessed
following deflagellation at several time points and compared to
pretreatment values as described [46].
Statistical Analyses
Data are expressed as mean 6 standard deviation (SD).
Statistical comparisons between groups were made using unpaired
two-tailed Student’s t tests or single factor analysis of variance
(ANOVA) with Bonferroni correction.
Results and Discussion
The proband was an 18-year old male of Ashkenazi-Jewish
descent who presented with recurrent upper and lower respiratory
tract infections, beginning in early infancy. His parents and five
siblings were unaffected (Figure 1A). Pulmonary function
measures were normal, but CT of the chest revealed diffuse cystic
bronchiectasis, primarily involving the right middle lobe, lingula,
and both lower lobes (total Brody score, 27.75 [33]) (Figure 1B).
Imaging of the paranasal sinuses demonstrated opacification of the
maxillary and ethmoid sinuses. Sputum cultures performed during
follow-up visits grew Haemophilus influenza, methicillin-sensitive
Staphylococcus aureus, and intermittently, Pseudomonas aeruginosa.
Cystic fibrosis was excluded by normal sweat test, normal nasal
potential difference, and a negative genetic screen for common
CFTR mutations among the Ashkenazi-Jewish population. Nasal
nitric oxide levels were reduced (mean 34 ppb), a feature of PCD,
and an assessment that is rapidly emerging as a first-line test
[4,47,48]. However, repeat nasal turbinate epithelial biopsies for
ultrastructural analyses of the ciliary axoneme by transmission
electron microscopy consistently revealed normal ciliary structure
(Figure 1C). Sperm motility analysis was offered, but it was
declined by the subject.
A search for homozygous regions was performed on the DNA
sample from the proband and revealed five homozygous regions
longer than 2 Mb (chr2:209.1-212.7, chr9:92.1-96.8, chr11:47.8-
54.9, chr12:40.4-52.5, chr15:66.3-69.7 Mb). Haplotype analysis
using STR markers D9S287, D11S1313, D12S8, D12S368,
D15S131 of the parents and the 5 unaffected sibs retained only
regions in chr2 and chr12. Within these regions there were 172
protein-coding genes, though only 17 were annotated in the ciliary
proteome [5], and only one, CCDC65, was conserved across all
organisms with motile cilia and flagella. DNA sequencing of the 8
exons and the flanking introns regions of CCDC65 revealed a
single, novel mutation in exon 6, c.876_877delAT
(ch12:47598804-5), which was predicted to result in a frameshift
leading to a termination codon at position 293 (Figure 1D). The
mutation segregated with the disease in an autosomal recessive
pattern, with both parents and four healthy siblings heterozygous
for the mutation and one sibling was homozygous for the wild-type
allele. The mutation was not present in dbSNP135 or in the
Exome Variant Server, (NHLBI Exome Sequencing Project,
Seattle, WA), and sequencing the coding exons of CCDC65 did not
reveal mutations in 5 unrelated Ashkenazi-Jewish subjects with
PCD. The mutation was found in three of 733 anonymous
Ashkenazi-Jewish subjects, indicating a carrier rate of 1:244 in this
community.
The relationship between CCDC65 expression and ciliogenesis
was examined using primary cultures of hTEC [36]. Cell
preparations were allowed to differentiate by initiating an air-
liquid interface condition (ALI), and RNA was collected at
different time points. CCDC65 was initially detected during early
ciliated cell differentiation (Day 7 post ALI), and coincided with
the expression of the master ciliogenesis gene, FOXJ1 (Figure 2A),
suggesting that CCDC65 is associated with ciliogenesis. This
relationship was further established by assessing expression of the
CCDC65 orthologue, DRC2 in the biflagellated alga Chlamydomonas
reinhardtii. RNAseq expression of CCDC65 increased significantly
following deflagellation when compared to pretreatment values,
with expression elevated to 6.7-fold at 3 minutes, 13.6-fold at 10
minutes and 7.8-fold at 30 minutes before returning to near
baseline (2.1-fold) levels at 60 minutes (Figure 2B), consistent with
transcriptional up-regulation of flagellar genes during cillogenesis
[46].
CCDC65 is the human orthologue of C. reinhardtii DRC2, which
is a component of the nexin-dynein regulatory complex
(Figure 3A), a structure important for regulating and orchestrat-
ing dynein activity, maintaining outer doublets alignment and
limiting the sliding of microtubules during bending [30,31].
CCDC65 was previously identified as NYD-SP28, a testis
developmental protein that localized to the tail of the sperm
[49]. The mutation identified in the affected individual resulted in
deletion of nucleotides in CCDC65 predicted to generate a
premature stop codon, resulting in a truncated and likely unstable
protein. Motif analysis of the full length-protein CCDC65 showed
clusters of phosphorylation, N-glycosylation and N-myristoylation
sites, many of which are located at the C’-terminus of the protein.
The mutant protein, even if stable would therefore lack important
post-translational modification sites [49].
To understand the roles of CCD65 in cilia assembly and
function, we evaluated CCDC65 expression and cilia phenotypes
in human airway epithelial cells. Nasal epithelial cells obtained
from the affected and normal subjects were immunostained for
CCDC65 Mutation Causes PCD
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CCDC65 (Figure 3B). The protein was detected in the cilia and
cytoplasm of airway epithelial cells collected from healthy subjects,
but was absent in PCD cells.
The impact of CCDC65 mutations on cilia function was
examined by evaluating the cilia beat patterns using high-speed
video imaging. Nasal epithelial cells collected from the PCD
subject were assayed as previously described [4,37], and measured
CBF was 14.5260.07 Hz, compared to 10.8960.29 Hz from
non-PCD subjects (Figure 4A). When examining the cilia beat
pattern of ciliated cell clusters, the cilia appeared stiff and
hyperkinetic, with a limited cilia stroke compared to cilia from
non-PCD controls (video S1 and S2). To precisely assess ciliary
beat patterns and minimize secondary environmental effects on
cilia motion [29], CCDC65 was silenced using RNAi in airway
epithelial cells obtained from tracheobronchial tissue of healthy
lung transplant donors. Airway epithelial cells were transduced
with recombinant lentivirus expressing CCDC65-specific shRNA
then differentiated at ALI [36]. CCDC65 mRNA was reproducibly
inhibited by different CCDC65-specific shRNA sequences when
compared to cells transduced with a non-targeted shRNA
sequence, as determined using RT-PCR (Figure S1). Cilia were
present on the apical surface of cells treated with all shRNA
sequences, which indicated that CCDC65 is not required for
ciliogenesis. To evaluate the ciliary beat patterns, hTEC were
lifted from the culture filters, to form cell clusters that were
transferred to glass slides, which permitted cilia motion to be
viewed and imaged in the lateral dimension. The CBF measured
in cultured hTEC transduced with targeted shRNA sequences was
higher than control non-targeted cells (p,0.05, ANOVA with
Bonferreoni correction; n= 5 captured fields per Transwell
culture, 10 Transwell samples per shRNA sequence)
(Figure 4B). The variability in CBF observed in the different
CCDC65-targeted shRNA groups is a reflection of the degree of
gene suppression. Moreover, beating cilia appeared dyskinetic,
with limited bending at the proximal portion of the cilia, which
contributes to a reduced stroke (video S3, S4, S5, S6).
To determine how mutant CCDC65 contributes to altered cilia
motion, we evaluated changes in another N-DRC protein. GAS8,
also known as DRC4, is a microtubule-binding protein that is an
integral part of the N-DRC. Gas8 maintains the alignment
between outer doublet microtubules during axonemal bending
and is proposed to be positioned in contact with DRC2 in C.
reinhardtii [31,50]. Like CCDC65, immunostaining revealed that
GAS8 was absent in ciliated nasal epithelial cells isolated from the
PCD subject when compared to cells collected from normal
volunteers (Figure 5). This finding suggests a role of CCDC65 is
the assembly and maintenance of the protein components of the
N-DRC and thus the regulation of cilia motion.
Changes in the N-DRC are subtle and might be missed or not
detected using standard transmission electron microscopy. This is
also the case for a PCD-causing mutation in CCDC164 (DRC1),
another member of the N-DRC, that results in very minor changes
in transmission electron micrographs and could be easily
overlooked [28]. Recent studies from large multicenter consortia
have shown that roughly one-third of individuals with clinical and
diagnostic features consistent with PCD do not have ultrastruc-
tural changes, further emphasizing the need for better diagnostic
testing [4,15,51]. Moreover, given the role of the N-DRC in
regulating cilia motility, it is possible that mutations in genes that
code for additional members of this complex account for PCD in
some cases.
While the number of genotypes causing PCD is expanding, we
cannot yet identify specific genotype-phenotype relationships. Of
interest, the PCD subject we describe with a mutation in CCDC65
did not have laterality defects, similar to other reported PCD
subjects with mutations in other N-DRC genes [28]. Moreover,
based on the medical history obtained from our reported family,
we have no evidence of laterality defects associated with this
family. However, we cannot exclude the possibility that CCDC65
mutations can also cause randomization of left-right body
asymmetry in humans. Moreover, CCDC65 was previously
localized to the tail of the sperm [49], and based on the observed
effects of mutations in CCDC65 on cilia motility; it is possible that
PCD subjects harbouring these mutations have reduced fertility.
In conclusion, we describe a PCD-causing mutation in a novel
gene, CCDC65, from a subject with classic clinical features and
markedly reduced nasal nitric oxide levels, but normal axonemal
ultrastructure and subtle impairment of ciliary motility. This
contributes to the expanding number of mutations associated with
this genetically heterogeneous disease, indicates the important role
of the N-DRC in normal airway epithelial cell function, and the
importance of developing sensitive and specific screening tests for
PCD.
Supporting Information
Figure S1 CCDC65 expression in normal human airway
epithelial cells following RNAi transduction. Primary
culture human airway epithelial cells were transduced with non-
targeted or CCDC65-specific shRNA using lentivirus. Following
differentiation using air-liquid interface conditions, RNA was
isolated and CCDC65 expression assessed. RT-PCR demonstrated
efficient silencing of CCDC65 expression using different shRNA
sequences (shRNA1, shRNA2, shRNA3) compared to non-
targeted controls (NT).
(TIF)
Video S1 Nasal epithelial cells from a subject with PCD
at normal speed. Nasal epithelial cells isolated from the PCD
subject with the CCDC65 mutation at normal speed.
(MP4)
Video S2 Nasal epithelial cells from a subject with PCD
at reduced speed. Nasal epithelial cells isolated from the PCD
subject with the CCDC65 mutation at reduced speed showing
dyskinetic cilia motion.
(MP4)
Video S3 Non-targeted shRNA transduced cultured
hTEC at normal speed. Non-targeted shRNA-treated hTEC,
shown at normal demonstrated normal cilia motion.
(MP4)
Video S4 Non-targeted shRNA transduced cultured
hTEC at reduced speed. Non-targeted shRNA-treated hTEC,
shown at reduced speed demonstrated normal cilia motion.
(MP4)
Video S5 CCDC65 shRNA transduced hTEC at normal
speed. hTEC transduced with CCDC65 specific shRNA, shown
at normal speed, revealing dyskinetic cilia motion.
(MP4)
Video S6 CCDC65 shRNA transduced hTEC at reduced
speed. hTEC transduced with CCDC65 specific shRNA, shown
at reduced speed, revealing dyskinetic cilia motion.
(MP4)
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